Shinichi Takatsuki

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Tohru Kobayashi, Tsutomu Saji, Tetsuya Otani et al. · The Lancet · 2012 · 674 citations

Medicine, Cardiology, Pharmacotherapy +11

A genome-wide association study identifies three new risk loci for Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Burns et al. · Nature Genetics · 2012 · 337 citations

Life Sciences, Genetics, Molecular Genetics +13

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Common variants in CASP3 confer susceptibility to Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Buns et al. · Human Molecular Genetics · 2010 · 176 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events

Masaru Miura, Tohru Kobayashi, Tetsuji Kaneko et al. · JAMA Pediatrics · 2018 · 148 citations · Full text

Medicine, Cardiology, Internal Medicine +17